Double maintains 4 strategies that include IONS - Ionis Pharmaceuticals, Inc.
Current Value
$30.171 Year Return
Current Value
$30.171 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NTZ | 0.01% | $54.08M | -21.44% | 0.00% |
ANF | -0.03% | $3.85B | -42.07% | 0.00% |
DVA | -0.05% | $12.24B | +10.98% | 0.00% |
NNVC | -0.06% | $18.30M | -10.00% | 0.00% |
LBRDK | 0.11% | $12.19B | +52.56% | 0.00% |
IRBT | -0.12% | $82.70M | -68.12% | 0.00% |
EC | -0.13% | $21.46B | -13.79% | 14.98% |
PBT | 0.15% | $461.89M | -20.14% | 4.94% |
E | -0.16% | $47.07B | -2.86% | 6.76% |
NEUE | -0.19% | $58.51M | +7.28% | 0.00% |
PSQH | 0.21% | $98.27M | -53.36% | 0.00% |
FLNG | 0.23% | $1.24B | -10.48% | 12.90% |
GOGL | 0.23% | $1.59B | -38.14% | 13.01% |
ACDC | 0.24% | $1.22B | -10.92% | 0.00% |
TXO | 0.26% | $788.77M | +5.22% | 12.55% |
GIS | -0.27% | $32.74B | -14.74% | 3.99% |
RLMD | -0.29% | $8.15M | -94.47% | 0.00% |
GEL | 0.30% | $1.92B | +38.24% | 4.02% |
MO | -0.31% | $101.47B | +38.87% | 6.74% |
SG | 0.32% | $2.93B | -1.34% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ALNY | 49.59% | $35.12B | +76.10% | 0.00% |
ARWR | 44.36% | $1.75B | -54.89% | 0.00% |
IDYA | 43.59% | $1.43B | -61.48% | 0.00% |
RCKT | 43.21% | $711.22M | -75.04% | 0.00% |
ARGX | 41.52% | $35.96B | +48.96% | 0.00% |
BEAM | 40.68% | $1.95B | -40.20% | 0.00% |
RARE | 39.45% | $3.35B | -22.91% | 0.00% |
ROIV | 38.89% | $7.20B | -3.26% | 0.00% |
CRNX | 36.96% | $3.12B | -27.92% | 0.00% |
RVMD | 36.77% | $6.57B | +11.62% | 0.00% |
IMVT | 36.26% | $2.90B | -45.93% | 0.00% |
DNLI | 36.25% | $1.97B | -33.88% | 0.00% |
COGT | 36.23% | $681.96M | -13.19% | 0.00% |
RXRX | 36.09% | $2.13B | -43.54% | 0.00% |
XNCR | 35.83% | $749.71M | -51.46% | 0.00% |
BMRN | 35.74% | $13.49B | -18.84% | 0.00% |
ALLY | 34.92% | $11.20B | -7.88% | 3.30% |
CRSP | 34.87% | $2.92B | -50.09% | 0.00% |
IMNM | 34.52% | $585.18M | -69.56% | 0.00% |
SDGR | 34.50% | $1.44B | -25.03% | 0.00% |
Yahoo
CARLSBAD, Calif., March 31, 2025--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:
Yahoo
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SeekingAlpha
RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with stability and specificity. Explore more details here.
Yahoo
Sobi will handle the upcoming regulatory filings and commercialisation in the agreed territories.
Yahoo
In return, Ionis will receive an undisclosed upfront payment from Sobi. It is also eligible to receive milestone payments and a tiered royalty on the drug's future sales.
Yahoo
Ionis Pharmaceuticals (IONS) said Wednesday it has entered into a license agreement with Sobi that a
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -24.33% | $195.31M | 0.85% |
BTAL | -23.56% | $404.97M | 1.43% |
TAIL | -21.46% | $86.92M | 0.59% |
TPMN | -20.75% | $33.51M | 0.65% |
BIL | -10.88% | $41.08B | 0.1356% |
ULST | -10.04% | $587.03M | 0.2% |
TFLO | -9.49% | $6.78B | 0.15% |
UNG | -8.61% | $434.44M | 1.06% |
SPSK | -8.32% | $296.56M | 0.5% |
BUXX | -8.00% | $231.44M | 0.25% |
UUP | -7.88% | $327.80M | 0.77% |
UGA | -7.68% | $88.11M | 0.97% |
DBE | -7.40% | $54.58M | 0.77% |
USDU | -7.24% | $213.46M | 0.5% |
USL | -7.10% | $46.60M | 0.85% |
TBLL | -6.94% | $2.07B | 0.08% |
USCI | -6.93% | $236.09M | 1.07% |
CTA | -6.57% | $963.19M | 0.76% |
IBDQ | -6.21% | $3.18B | 0.1% |
FXY | -6.11% | $546.19M | 0.4% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -21.15% | $23.69B | +24.42% | 1.08% |
CME | -13.88% | $95.61B | +25.13% | 3.98% |
LITB | -13.18% | $36.77M | -56.14% | 0.00% |
LFVN | -11.37% | $183.00M | +128.17% | 1.05% |
TCTM | -10.69% | $3.39M | -83.19% | 0.00% |
EXC | -9.72% | $46.52B | +23.77% | 3.35% |
VZ | -9.10% | $190.95B | +7.28% | 5.89% |
HEES | -8.91% | $3.47B | +50.53% | 1.16% |
CB | -7.63% | $120.92B | +17.32% | 1.20% |
CCEC | -7.19% | $1.12B | +11.47% | 3.12% |
CHD | -7.00% | $27.09B | +4.83% | 1.03% |
AVO | -6.98% | $744.83M | -10.96% | 0.00% |
K | -6.15% | $28.48B | +44.57% | 2.75% |
KR | -6.09% | $48.98B | +18.78% | 1.86% |
ED | -5.89% | $39.05B | +22.43% | 3.04% |
JKHY | -5.74% | $13.31B | +7.12% | 1.21% |
CVGW | -4.73% | $427.90M | -12.38% | 2.09% |
MNOV | -4.56% | $71.61M | -0.68% | 0.00% |
DKL | -4.48% | $2.32B | +6.42% | 10.03% |
SPTN | -4.42% | $684.07M | +2.07% | 4.31% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
UTWO | -0.05% | $377.34M | 0.15% |
ITM | -0.18% | $1.90B | 0.18% |
BCD | 0.18% | $249.09M | 0.3% |
HYMB | 0.20% | $2.74B | 0.35% |
VGSH | 0.20% | $22.40B | 0.03% |
SCHO | -0.20% | $10.95B | 0.03% |
BSCP | -0.26% | $3.67B | 0.1% |
SGOV | 0.27% | $39.39B | 0.09% |
IBMR | -0.28% | $220.57M | 0.18% |
PULS | -0.28% | $10.97B | 0.15% |
FTSM | -0.29% | $6.39B | 0.45% |
MLN | 0.30% | $531.96M | 0.24% |
IVOL | 0.32% | $479.06M | 1.02% |
BCI | 0.40% | $1.43B | 0.26% |
SHV | 0.48% | $20.11B | 0.15% |
CGSM | 0.54% | $636.53M | 0.25% |
CMDY | 0.56% | $306.57M | 0.28% |
OWNS | -0.60% | $134.66M | 0.3% |
IBMO | -0.64% | $505.83M | 0.18% |
MMIN | -0.67% | $471.66M | 0.3% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 56.38% | $5.33B | 0.35% |
IBB | 55.69% | $5.92B | 0.45% |
FBT | 53.36% | $1.08B | 0.56% |
PBE | 52.13% | $233.11M | 0.58% |
BBH | 50.86% | $368.79M | 0.35% |
GNOM | 50.67% | $53.29M | 0.5% |
PINK | 47.47% | $141.43M | 0.5% |
ARKG | 44.89% | $977.87M | 0.75% |
VHT | 43.45% | $16.42B | 0.09% |
XPH | 42.78% | $156.75M | 0.35% |
FHLC | 42.61% | $2.69B | 0.084% |
IYH | 41.45% | $3.18B | 0.39% |
IXJ | 41.08% | $3.93B | 0.41% |
IHE | 39.93% | $600.56M | 0.39% |
FXH | 39.50% | $960.13M | 0.62% |
PTH | 38.71% | $110.42M | 0.6% |
XLV | 37.70% | $38.07B | 0.09% |
QQQJ | 36.89% | $594.32M | 0.15% |
CPRJ | 36.01% | $48.46M | 0.69% |
IWO | 34.49% | $10.88B | 0.24% |